The performance of companies tied to iconic drugs like Viagra presents a complex investment picture. While the initial rise of copyright, fueled by Viagra's extraordinary popularity, generated substantial wealth , the loss of exclusivity in key regions has introduced substantial volatility. Investors are now facing the effect of rival medications ,